HR-17020

N/A

Report date: 2023/04/14 10:50:42
NME

Base Information

Drug NameHR-17020
Drug Alias NameHR17020HR-17020
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor Xa inhibitors
TargetsCoagulation factor X
Therapy Area/IndicationsVenous ThromboembolismThromboembolismNephrotic Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Hengrui Medicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Hengrui Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsVenous ThromboembolismNephrotic Syndrome
Inactive IndicationsThromboembolism

Other Information

ATC CodeN/A
Related LinksN/A